Respiratory disorders, especially non-communicable, chronic inflammatory diseases, are
amongst the leading causes of mortality and morbidity worldwide. Respiratory diseases …

Guideline-based management of asthma focuses on disease severity and choosing the
appropriate medical therapy to control symptoms and reduce the risk of exacerbations …

Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

Asthma is a serious health problem throughout the world. During the past two decades,
many scientific advances have improved our understanding of asthma and ability to manage …

Inhaled corticosteroids (ICS) are the most effective controllers of asthma. They suppress
inflammation mainly by switching off multiple activated inflammatory genes through …

Background Anti‐leukotrienes (5‐lipoxygenase inhibitors and leukotriene receptors
antagonists) serve as alternative monotherapy to inhaled corticosteroids (ICS) in the …

Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes,
not all of which may be encompassed in the subjects included in randomised controlled …

Abstract The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma
guidelines for the diagnosis and management of asthma for adults and children, which is …

Бронхиальная астма-одно из наиболее распространённых заболеваний дыхательных
путей (около 7% взрослых и 10% подростков и детей страдают бронхиальной астмой в …

Objective: The objective of this study was to evaluate montelukast 10 mg daily as treatment
for allergic rhinitis in patients with symptomatic allergic rhinitis and active asthma during the …